Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 275

Li Auto lines up US flotation

Meituan Dianping is the largest investor in the China-based smart electric vehicle producer, which has set a $100m placeholder target for its initial public offering.

Jul 14, 2020

Coupang collects Hooq assets

The SingTel, WarnerMedia and Sony-backed streaming service filed for liquidation in March and has reportedly agreed to let Coupang buy its assets.

Jul 14, 2020

CyberAgent Capital secures new team members

CyberAgent has added seven team members at its corporate venturing unit in a bid to help portfolio companies in areas including technical aspects and public relations.

Jul 13, 2020

Nissay Capital announces 50M’s third batch

Nippon Life’s accelerator initiative has announced its latest members, who will work towards a demo day scheduled for March 2021.

Jul 13, 2020

Alphabet allocates $10bn to Indian investments

Alphabet and its Google subsidiary will back India-based companies as part of its newly formed Google for India Digitization Fund.

Jul 13, 2020

Qualcomm mobilises $97m for Jio Platforms

Reliance's 5G-focused digital network spinoff has added Qualcomm Ventures to an investor base that already includes Intel Capital and Facebook.

Jul 13, 2020

Flipkart picks part of Arvind Youth Brands

Flipkart has paid $34.6m for a minority stake in Arvind Youth Brands as part of a strategic partnership to jointly explore market opportunities for its fashion apparel.

Jul 13, 2020

Corporate venturing deal net: 6-10 July 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jul 10, 2020

XM Cyber executes $17m series B

Nasdaq Ventures returned to reinvest in the cybersecurity software developer through a round that hiked its overall funding to $49m.

Jul 10, 2020

Harbour BioMed hoards series C funding

The Zhejiang University Future Capital-backed cancer and inflammatory disease drug developer has now raised more than $260m in under two years.

Jul 10, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here